Organization
Regeneron Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Regeneron Pharmaceuticals, Inc.
... Genentech, Agency Partner: Heartbeat PRALUENT® Market Access Team, Sanofi US and Regeneron Pharmaceuticals, Inc., Agency Partner: Entrée Health Promius Dermatology Marketing Team, Promius Pharma, Agency ...
... biotech companies. The share pri­ces of large market-cap-weighted companies ­Celgene Corp and Regeneron Pharmaceuticals, for example, have declined 27% and 31% respectively over the last ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi today announced that the first positive Phase 1 ...
... regulatory submission for patients ages 12-17 planned for third quarter 2018 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi today announced that a pivotal Phase 3 trial ...
... acuity over time and measuring retinal thickness using standard optical coherence tomography (OCT).Regeneron collaboration continues for the development of OTX-IVT (aflibercept implant). The Company, along ...
... combined with electronic medical records to help providers treat chronic conditions. ( Regeneron Pharmaceuticals and Sanofi will slash the list price of Praluent, a cholesterol-lowering ...
... displayed award-winning proficiency. Orlovsky, 18, won second place and $175,000 in the Regeneron Science Talent Search in March for her research on electronic cigarettes. That ...
... have taken issue with ICER and its drug economic analyses. Amgen and Regeneron previously blasted the organization of using flawed methods to assess their new ...
... Frustrated by tepid sales and practical stumbling blocks, Regeneron and Sanofi are offering a huge discount on their treatment for bad ...
Subscribe now for full coverage on Regeneron Pharmaceuticals, Inc.
Start My Free Trial